EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LRH ‐1 activation alleviates diabetes‐induced podocyte injury by promoting GLS2 ‐mediated glutaminolysis

Jijia Hu iD, Zongwei Zhang, Hongtu Hu, Keju Yang, Zijing Zhu, Qian Yang, Wei Liang

Cell Proliferation · 2023

DOI: 10.1111/cpr.13479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, 2023. Verfasst von Jijia Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Nephropathies, Podocytes. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alteration of metabolic phenotype in podocytes directly contributes to the development of albuminuria and renal injury in conditions of diabetic kidney disease (DKD). This study aimed to identify and evaluate liver receptor homologue‐1 (LRH‐1) as a possible therapeutic target that alleviates glutamine (Gln) metabolism disorders and mitigates podocyte injury in DKD. Metabolomic and transcriptomic analyses were performed to characterize amino acid metabolism changes in the glomeruli of diabetic mice. Next, Western blotting, immunohistochemistry assays, and immunofluorescence staining were used to detect the expression of different genes in vitro and in vivo. Furthermore, Gln and glutamate (Glu) content as well as ATP generation were examined. A decrease in LRH‐1 and glutaminase 2 (GLS2) expression was detected in diabetic podocytes. Conversely, the administration of LRH‐1 agonist (DLPC) upregulated the expression of GLS2 and promoted glutaminolysis, with an improvement in mitochondrial dysfunction and less apoptosis in podocytes compared to those in vehicle‐treated db/db mice. Our study indicates the essential role of LRH‐1 in governing the Gln metabolism of podocytes, targeting LRH‐1 could restore podocytes from diabetes‐induced disturbed glutaminolysis in mitochondria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetic NephropathiesPodocytesAnimalsMiceKidneyKidney GlomerulusReceptors, Cytoplasmic and NuclearGlutaminase

Substanzen

Nr5a2 protein, mouseReceptors, Cytoplasmic and NuclearGls2 protein, mouseGlutaminase

Autor:innen und Institutionen

  • Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
  • Nephrology and Urology Research Institute of Wuhan University, Wuhan, Hubei, China.
  • The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, China.

ORCID-Profile: Jijia Hu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province

Zitieren

APA

Hu, J., Zhang, Z., Hu, H., Yang, K., Zhu, Z., Yang, Q., & Liang, W. (2023). LRH ‐1 activation alleviates diabetes‐induced podocyte injury by promoting GLS2 ‐mediated glutaminolysis. Cell Proliferation. https://doi.org/10.1111/cpr.13479

Vancouver

Hu J, Zhang Z, Hu H, Yang K, Zhu Z, Yang Q, et al. LRH ‐1 activation alleviates diabetes‐induced podocyte injury by promoting GLS2 ‐mediated glutaminolysis. Cell Proliferation. 2023. doi:10.1111/cpr.13479

BibTeX
@article{Hu2023,
  author = {Hu, Jijia and Zhang, Zongwei and Hu, Hongtu and Yang, Keju and Zhu, Zijing and Yang, Qian and Liang, Wei},
  title = {LRH ‐1 activation alleviates diabetes‐induced podocyte injury by promoting GLS2 ‐mediated glutaminolysis},
  journal = {Cell Proliferation},
  year = {2023},
  doi = {10.1111/cpr.13479}
}
Kostenlos starten →